Abstract:Preeclampsia is a pregnancy-specific illness that is hypothesized to occur due to vitamin D deficiency during pregnancy. Therefore, vitamin D supplementation in early pregnancy should be explored for preventing preeclampsia and promoting neonatal well-being. The present study follows a case-control analysis that aims to determine the effect of vitamin D supplements on reducing the probability of recurrent preeclampsia. We identified 59 patients for the control group without vitamin D supplementation during pregnancy, while 139 patients were included in the cases group of pregnant women with a history of preeclampsia who confirmed taking daily vitamin D supplements in either 2000 UI or 4000 UI until the 36th week of pregnancy. There were 61 (80.3%) patients with a normal serum vitamin D level measured at 32 weeks in the pregnant women who took a daily dose of 4000 UI vitamin D and 43 (68.3%) in those who took a 2000 UI dose of vitamin D, compared to just 32 (54.2%) in those who did not take vitamin D at all. Regarding the blood pressure of pregnant women measured at 32 weeks, it was observed that 20.3% were hypertensive in the no supplementation group, compared to only 11.1% and 6.6% in those who were taking vitamin D during pregnancy (p-value = 0.049). Serum vitamin D levels at 32 weeks were measured at an average value of 23.9 ng/mL, compared with 28.4 ng/mL in the group taking a 2000 UI daily dose and 33.6 in those who supplemented with 4000 UI daily (p-value < 0.001). Proteinuria was identified more often in the group at risk for preeclampsia who did not take vitamin D supplements, while systolic blood pressure (p-value = 0.036) as well as diastolic blood pressure (p-value = 0.012), were all identified to have significantly higher values in the pregnant women with a history of preeclampsia that did not take vitamin D during the current pregnancy. The significant risk factors for preeclampsia development in pregnant patients at risk are: insufficient vitamin D serum levels (<20 ng/mL), OR = 2.52; no vitamin D supplementation, OR = 1.46; more than two pregnancies, OR = 1.89; gestational diabetes mellitus, OR = 1.66; and cardiovascular comorbidities, OR = 2.18. These findings imply that vitamin D has a role in the preservation of placental function and, therefore, in the prevention of the development of late preeclampsia. Pregnant mothers who supplemented their diets with vitamin D were protected against preeclampsia recurrence. Vitamin D supplementation during pregnancy may aid in the prevention of gestational hypertension and preeclampsia.

Comparison of Serum level of Vitamin D in Pregnant Women with Preeclampsia and a Control Group in Ayatollah Mousavi Hospital in Zanjan

Comparison of Serum Vitamin D Levels in Patients with Severe Preeclampsia and Normal Pregnancy at Dr. Zainoel Abidin Regional General Hospital Banda Aceh

Comparing levels of vitamin D, calcium and phosphorus in normotensive pregnant women and pregnant women with preeclampsia

The evaluation of serum homocysteine, folic acid, and vitamin B12 in patients complicated with preeclampsia

Could vitamin D3 be effective in prevention of risk of preeclampsia among pregnant women?

Vitamin D and preeclampsia: A systematic review and meta-analysis

Evaluation of the Effect of Vitamin D Levels During the Last Trimester of Pregnancy on Fetomaternal Outcomes in Patients With Preeclampsia

Comparison of the Level of Vitamin D in Preterm Infected and Uninfected Infants

The effect of vitamin D supplementation in pregnancy on the incidence of preeclampsia: A systematic review and meta-analysis

The Effects of Vitamin D Supplementation on glycemic indices, lipid profile and blood pressure of pregnant women with Vitamin D deficiency: A Single arm Clinical Trial

A STUDY OF SERUM LEVELS OF 25 (OH)VITAMIN D AND CALCIUM IN PRE-ECLAMPSIA, ECLAMPSIA AND NORMAL HEALTHY PREGNANT WOMEN

Plasma Levels of Vitamin A in Early Pregnancy and Correlationship with Hypertensive Disorder

Serum Vitamin D Concentrations and Covid-19 In Pregnant Women, Does Vitamin D Supplementation Impact Results? A Comprehensive Study

Association between Vitamin D Deficiency and Preeclampsia among Pregnant Females during First Trimester

Association of Maternal Serum 25-Hydroxyvitamin D Concentrations with Risk of Preeclampsia: a Nested Case-Control Study and Meta-Analysis

Vitamin D deficiency and pregnancy outcome: Does it have a role in preeclampsia etiology?

Study of Serum Homocysteine, Folic Acid and Vitamin B12 in Patients with Preeclampsia

Obstetric and neonatal outcomes of maternal vitamin D supplementation: results of an open-label, randomized controlled trial of antenatal vitamin D supplementation in Pakistani women

Comparison of Vitamin D Status between Healthy Pregnant Women and Women with Recurrent Early Spontaneous Pregnancy Loss

Relationship Between Serum Resistin Level and Preeclampsia

The Influence of Maternal Vitamin D Supplementation in Pregnancies Associated with Preeclampsia: A Case-Control Study